Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT02145117 Active, not recruiting - Clinical trials for Post Traumatic Headache

Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)

MBSR-PTH
Start date: September 2013
Phase: N/A
Study type: Interventional

This project aims to develop and test structural and functional brain imaging biomarkers for improvement in chronic pain from a mind/body intervention perspective in a critical veteran population, namely veterans with post traumatic headache (PTH) associated with mild traumatic brain injury (TBI). The project also aims to examine feasibility in a sample of veterans with PTH of performing resting state and structural neuroimaging protocols, and of obtaining active participation and completion of MBSR training. Lastly, exploratory analysis of brain imaging data will be performed to determine if hypothesized candidate biomarkers are associated with positive outcomes from MBSR and determine estimated effect sizes for future studies in PTH population.

NCT ID: NCT02141568 Terminated - Chronic Pain Clinical Trials

Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained Symptoms (MUS)

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to check the medical efficacy and economic benefits of multidisciplinary care in patients with unexplained medical complaints and consume medical services frequently.

NCT ID: NCT02138474 Completed - Clinical trials for Chronic Tension-type Headaches

The Efficacy of Lacticum Acidum Homaccord in the Treatment of Chronic Tension-type Headaches

Start date: April 2014
Phase: Phase 2
Study type: Interventional

Chronic tension-type headaches (CTTHs) affect 30-40% of the population and account for a number of absences from, and decreased performances at, work and school as well as recreational activities. CTTHs typically occur at least 15 times a month or at least every second day, and present as an achy or tight sensation that is felt around the head . The pain may last from 30 minutes to several days and varies in intensity . Conventional treatment is palliative, consisting of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), which may produce adverse effects and analgesic rebound headaches . Lacticum acidum 30CH is a homoeopathic remedy that has been shown to have potential benefits in the treatment of CTTHs . Homaccords are the preparation of one remedy in multiple increasing potencies in a single vehicle . There has been no research done to date on Lacticum acidum Homaccord in the treatment of CTTHs.The aim of this study is to determine the efficacy of Lacticum acidum Homaccord in the treatment of chronic tension-type headaches, using the modified Headache Diary and the Headache Disability Inventory.

NCT ID: NCT02122419 Completed - Pregnancy Clinical Trials

The Effect of Patient Position on Postdural Puncture Headache

Start date: April 2014
Phase: N/A
Study type: Observational

We aimed to investigate the association between the position in which spinal anesthesia was performed and postdural puncture headache occurrence.

NCT ID: NCT02120326 Completed - Clinical trials for Chronic Migraine as Defined by Criteria of International Headache Society (IHS)

Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine

Medis
Start date: May 5, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether TDCS is an effective prophylactic therapy of chronic migraine.

NCT ID: NCT02115269 Completed - Clinical trials for Migraine Without Aura

IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice

PRESTO
Start date: June 2014
Phase: N/A
Study type: Observational

Headaches are a common medical problem that physicians frequently encounter in their practice. One of key findings of The Atlas of Headache Disorders prepared by World Health Organization (WHO) is: headache disorders, including migraine and tension-type headache (TTH), are among the most prevalent disorders of mankind. The fixed combination of indomethacin, prochlorperazine and caffeine (IndoProCaf) showed efficacy and safety in acute treatment of migraine and episodic tension-type headache attacks. IndoProCaf (Difmetre®) is widely used in common daily practice only in Italy from early 1970s, is available at the Commonwealth of Independent States (CIS) pharmaceutical market now. There are limited data regarding IndoProCaf usage from post-marketing settings. This will be a first post-marketing observational study which aimed to evaluate the effectiveness and patients' satisfaction of primary headaches acute treatment in routine clinical settings in Ukraine and Kazakhstan.

NCT ID: NCT02113111 Completed - Clinical trials for Cardiovascular Diseases

Effects of Fasting on Self Efficacy

TheraFast
Start date: April 2014
Phase: N/A
Study type: Observational

The study aims to investigate - if a 7 day therapeutic fasting regimen will affect self-efficacy of patients with chronic diseases - the effects of fasting on physical and mental well-being, quality of life and body awareness/image - the association between patients characteristics and the perceived health benefit after fasting - the association between Diagnosis according to traditional Chinese medicine and physical and mental well-being during the course of fasting - experiences and perceptions of patients during fasting therapy

NCT ID: NCT02098499 Completed - Nausea Clinical Trials

Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Haloperidol is known to be a safe alternative medication to control difficult pain, and has been shown effective when compared to placebo for controlling headaches. Investigators hypothesized that the combination of haloperidol and diphenhydramine would be a useful medication choice for migraine headache patients in the emergency department in comparison to a common migraine treatment regimen of metoclopramide and diphenhydramine.

NCT ID: NCT02090998 Terminated - Clinical trials for Chronic Daily Headache

Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines

Start date: May 2014
Phase: Phase 4
Study type: Interventional

This study will compare a local anesthetic technique that has been used to treat subjects suffering from transformed migraines (chronic migraines) versus medical management with traditional antidepressant Amitriptyline / Elavil. Subjects will be randomized into one of two treatment groups to compare the safety and efficacy of the therapies. Subjects will recieve either sphenopalatine ganglion nerve block with 5% lidocaine gel into the nasopharynx or medical management with traditional antidepressants, Elavil, to produce a reduction in the frequency and severity of the headache. We propose that there will be a difference in the outcomes when comparing the two methods of treating transformed migraines and that one research arm will result in more patient satisfaction and greater efficacy in the treatment of subjects

NCT ID: NCT02081482 Recruiting - Clinical trials for Refractory Chronic Cluster Headache

Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation

MET-ONS
Start date: March 2014
Phase: N/A
Study type: Interventional

The occipital nerve stimulation (ONS) is used to treat patients with refractory primary chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis have been suggested in particular a specific action on cerebral generators involved in different types of primary headaches or a non specific action on pain modulatory network. The aim of this study, using the chronic cluster headache as a model, is to determine the changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary chronic headache.